Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin versus misoprostol for cervical ripening before hysteroscopy
IRCT20220203053929N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of nitroglycerin and misoprostol (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Cervical dilation before hysteroscopy. Started Apr 2022; status: completed.
02
Drugs
nitroglycerinmisoprostol
Beyond the preview
Go deeper on IRCT20220203053929N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220203053929N1.